Project Code: 10446051
Faculty: Liggins Institute
Department: Liggins Institute
Main Supervisor: Dist Prof Jane Harding
Principal investigator: Professor Caroline Crowther
Application open date: 22 Feb 2019
Application deadline: 31 Jan 2021
Enrolment information: NZ Citizens, NZ Permanent Residents, International
Steroids given to women at risk of preterm birth markedly reduce the risk of serious illness in their newborn babies. Repeat doses are recommended if birth is delayed, but effects on adult health are not known.
We have completed the ACTORDS randomised trial comparing single with repeat doses of steroids, and have assessed those children’s growth and development at 6-8 years.
This project will involve assessing whether nationally collected data held in the government Integrated Data Structure (IDI) can be used to determine adult outcomes of babies whose mothers took part in the ACTORDS trial.
Masters or Honours degree or equivalent in a health or education-related discipline and a clinical background. Examples include (but are not limited to) neonatology, nursing, midwifery, paediatrics, obstetrics, public health, developmental or educational psychology, education.
Scholarships and awards are available to support Honours, Masters and PhD students at the Liggins Institute, including a Liggins Institute 'Start Up' Doctoral Scholarship for your first year's fees. Find out more.
Use the ACTORDS cohort to:
i) Compare IDI data with that collected by individual assessment at 6-8 years.
ii) Assess education, employment, health and social outcomes in young adulthood.
Here is more information about the ACTORDS study.
Here are links to the supervisors' biographies:
Crowther CA, Haslam RR, Hillier JE, Doyle LW, Robinson JS, for the Australasian Collaborative Trial of Repeat Doses of Steroids (ACTORDS) Study Group. Neonatal respiratory distress syndrome after repeat exposure to antenatal corticosteroids: a randomised controlled trial. Lancet 367: 1913-1919, 2006.
Crowther CA, Doyle LW, Haslam RR, Hiller JE, Harding JE, Robinson JS, for the ACTORDS Study Group. Outcomes at 2 years of age after repeat doses of antenatal corticosteroids. New England Journal of Medicine 357: 1179-89, 2007.
McKinlay CJD, Cutfield WS, Battin MR, Dalziel SR, Crowther CA, Harding JE on behalf of the ACTORDS Study Group. Cardiovascular risk factors in children after repeat doses of antenatal glucocorticoids: an RCT. Pediatrics 135: e405-415, 2015. DOI: 10.1542/peds.2014-2408
Crowther CA, Anderson PJ, McKinlay CJD, Harding JE, Ashwood PJ, Haslam, RR, Robinson JS, Doyle LW for the ACTORDS Follow-up Group. Mid-childhood outcomes of repeat antenatal corticosteroids: a randomized controlled trial. Pediatrics 138, e20160947, 2016.
Crowther CA, McKinlay CJD, Middleton P, Brown J, Harding JE. Repeat doses of prenatal corticosteroids for women at risk of preterm birth for improving neonatal health outcomes. Cochrane Database of Systematic Reviews Issue 7, Art. No.: CD003935. DOI: 10.1002/14651858.CD003935.pub4, 2015.
To learn more about what we do, visit https://www.auckland.ac.nz/en/liggins.html
- The current research of Professor Caroline Crowther
- Do lower thresholds for diagnosis of gestational diabetes have later benefits for mothers and babies?
- Do tighter glycaemic targets for managing gestational diabetes improve long-term outcomes for mothers? A data linkage study
- Do tighter glycaemic targets for managing gestational diabetes improve long-term outcomes for children? A data linkage study
- Cost consequences of different diagnostic strategies and different treatment targets for women with gestational diabetes